|
|
![]() |
![]() |
![]() |
![]() |
|
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
||||||||||||||||||||||||||||||||||||
| Sponsored by: |
Novartis |
| Information provided by: | Novartis |
| ClinicalTrials.gov Identifier: | NCT00377806 |
Purpose
This study will assess the efficacy, safety and tolerability of topically administered diclofenac gel versus placebo with respect to the symptom score (pain, temperature and size of erythema along the superficial vein)
| Condition | Intervention | Phase |
|
Superficial Thrombophlebitis of the Upper Limb |
Drug: Diclofenac gel |
Phase IV |
| MedlinePlus related topics: | Thrombophlebitis |
| ChemIDplus related topics: | Diclofenac Diclofenac potassium Diclofenac sodium |
| Study Type: | Interventional |
| Study Design: | Treatment, Randomized, Double-Blind, Placebo Control, Parallel Assignment, Safety/Efficacy Study |
| Official Title: | A One Week, Double-Blind, Adaptive, Randomized, Multicenter Study to Compare the Efficacy, Safety and Tolerability of Topical Diclofenac Gel Versus Placebo in Patients With Superficial Thrombophlebitis |
| Estimated Enrollment: | 200 |
| Study Start Date: | January 2003 |
| Study Completion Date: | September 2006 |
Eligibility
| Ages Eligible for Study: | 18 Years to 85 Years |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
Inclusion Criteria:
Exclusion Criteria:
Other protocol-defined exclusion criteria may apply
Contacts and Locations
More Information
| Study ID Numbers: | CVOL458UDE01 |
| First Received: | September 15, 2006 |
| Last Updated: | December 7, 2007 |
| ClinicalTrials.gov Identifier: | NCT00377806 |
| Health Authority: | Germany: Federal Institute for Drugs and Medical Devices |
|
|
|
|
|